Other News To Note
OrbiMed Advisors, of New York, launched a $222 million fund, OrbiMed Israel Partners LP, to focus on life sciences venture capital opportunities based in Israel. The fund is anchored by an investment from the government of Israel, which also provided special economic terms through the initial tender process for the fund.
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter